Hypertrophic Response and Keloid Diathesis: Two Very Different Forms of Scar

被引:147
作者
Burd, Andrew [1 ]
Huang, Lin [1 ]
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Div Plast & Reconstruct Surg, Shatin, Hong Kong, Peoples R China
关键词
D O I
10.1097/01.prs.0000191977.51206.43
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Hypertrophic and keloid scars remain extremely challenging, particularly in their variable response to treatment. The understanding of hypertrophic and keloid scarring is evolving from a position where they were regarded as different stages of the same process to the contemporary perspective of two separate entities. This article reviews the differences in the two forms of scarring and discusses the implications for future research. Methods: The authors conducted a MEDLINE search of all English language reviews linking key words "hypertrophic," "keloid," and "scarring." Results: Over the past four decades, there has been considerable clinical and experimental research looking at the biological nature and therapeutic response of keloid and hypertrophic scarring. As more differences are emerging regarding the fundamental biology of the scars, investigators are giving more detailed characterization of their source material. It is evident that even within the broad categories of hypertrophic and keloid scarring there is a heterogenous distribution of pathologic con-nective tissue matrix biology. Conclusion: Considerable advances have been made in our understanding of the fundamental biology of scarring. As research methodology becomes even more sophisticated, it will be even more crucial to extensively characterize source material, recognizing major differences not only between keloid and hypertrophic scar but also between scars of varying stages of maturation and histomorphological, biochemical, and molecular variations within individual scars. (Plast. Reconstr. Surg. 116: 150e, 2005.)
引用
收藏
页码:150E / 157E
页数:8
相关论文
共 57 条
[1]
ADEYEMI-DORO H O, 1976, African Journal of Medicine and Medical Sciences, V5, P93
[2]
Enhanced expression of caspase-3 in hypertrophic scars and keloid: Induction of caspase-3 and apoptosis in keloid fibroblasts in vitro [J].
Akasaka, Y ;
Ishikawa, Y ;
Ono, I ;
Fujita, K ;
Masuda, T ;
Asuwa, N ;
Inuzuka, K ;
Kiguchi, H ;
Ishii, T .
LABORATORY INVESTIGATION, 2000, 80 (03) :345-357
[3]
Hypertrophic scars and keloids - Etiology and management [J].
Alster, TS ;
Tanzi, EL .
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2003, 4 (04) :235-243
[4]
TREATMENT OF KELOID STERNOTOMY SCARS WITH 585 NM FLASHLAMP-PUMPED PULSED-DYE LASER [J].
ALSTER, TS ;
WILLIAMS, CM .
LANCET, 1995, 345 (8959) :1198-1200
[5]
Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids [J].
Amadeu, TP ;
Braune, AS ;
Porto, LC ;
Desmoulière, A ;
Costa, AMA .
WOUND REPAIR AND REGENERATION, 2004, 12 (02) :169-174
[6]
Amendt C, 2002, J CELL SCI, V115, P2189
[7]
Appleton I, 1996, AM J PATHOL, V149, P1441
[8]
Keloid disease: clinical relevance of single versus multiple site scars [J].
Bayat, A ;
Arscott, G ;
Ollier, WER ;
Mc Grouther, DA ;
Ferguson, MWJ .
BRITISH JOURNAL OF PLASTIC SURGERY, 2005, 58 (01) :28-37
[9]
Genetic susceptibility to keloid disease:: Transforming growth factor β receptor gene polymorphisms are not associated with keloid disease [J].
Bayat, A ;
Bock, O ;
Mrowietz, U ;
Ollier, WER ;
Ferguson, MWJ .
EXPERIMENTAL DERMATOLOGY, 2004, 13 (02) :120-124
[10]
Genetic susceptibility to keloid disease and hypertrophic scarring:: Transforming growth factor β1 common polymorphisms and plasma levels [J].
Bayat, A ;
Bock, O ;
Mrowietz, U ;
Ollier, WER ;
Ferguson, MWJ .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2003, 111 (02) :535-543